Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Slomovitz, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Nicole Concin, Prof.
Head of the Division of General Gynecology and Gynecologic Oncology at the Department of Obstetrics and Gynecology of MedUni Vienna and University
Principal Investigator - Stephanie Gaillard, MD, PhD
Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center (SKCCC)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
317 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Capital Federal, Argentina
Recruiting - Research Site
Ciudad Autonoma Buenos Aires, Argentina
Recruiting - Research Site
Ciudad de Buenos Aires, Argentina
Recruiting - Research Site
Cuidad Autónoma de Buenos Aire, Argentina
Recruiting - Research Site
Córdoba, Argentina
Not, yet, recruiting - Research Site
Córdoba, Argentina
Recruiting - Research Site
La Rioja, Argentina
Recruiting - Research Site
Pergamino, Argentina
Recruiting - Research Site
Viedma, Argentina
Recruiting
- Research Site
Malvern, Australia
Recruiting - Research Site
Melbourne, Australia
Recruiting - Research Site
Randwick, Australia
Recruiting - Research Site
St Leonards, Australia
Recruiting - Research Site
Subiaco, Australia
Recruiting - Research Site
Westmead, Australia
Recruiting
- Research Site
Graz, Austria
Recruiting - Research Site
Innsbruck, Austria
Recruiting - Research Site
Vienna, Austria
Recruiting
- Research Site
Brussels, Belgium
Not, yet, recruiting - Research Site
Brussels, Belgium
Recruiting - Research Site
Charleroi, Belgium
Recruiting - Research Site
Edegem, Belgium
Not, yet, recruiting - Research Site
Ghent, Belgium
Recruiting - Research Site
Ghent, Belgium
Not, yet, recruiting - Research Site
Leuven, Belgium
Recruiting - Research Site
Liège, Belgium
Recruiting - Research Site
Liège, Belgium
Not, yet, recruiting - Research Site
Namur, Belgium
Recruiting
- Research Site
Belo Horizonte, Brazil
Not, yet, recruiting - Research Site
Belém, Brazil
Not, yet, recruiting - Research Site
Bento Gonçalves, Brazil
Not, yet, recruiting - Research Site
Blumenau, Brazil
Recruiting - Research Site
Curitiba, Brazil
Withdrawn - Research Site
Curitiba, Brazil
Recruiting - Research Site
Florianópolis, Brazil
Not, yet, recruiting - Research Site
Joinville, Brazil
Not, yet, recruiting - Research Site
Natal, Brazil
Recruiting - Research Site
Porto Alegre, Brazil
Not, yet, recruiting - Research Site
Porto Alegre, Brazil
Recruiting - Research Site
Porto Alegre, Brazil
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2025
- Primary completion
- 15 Oct 2027
- Completion
- 17 Jul 2029
- Last update posted
- 10 Jun 2026
- Registered enrollment
- 800
- Registry id
- NCT07044336
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.